Congress Materials – Annual Fall Clinical Dermatology Conference for PAs & NPs (PANP360 2026)
2026 Annual Fall Clinical Dermatology Conference for PAs & NPs | May 29-31 | Scottsdale, AZ
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Durability of Icotrokinra (Targeted Oral Peptide) Effects in Adolescents With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the ICONIC-LEAD Study
Jennifer Soung, Mark G. Lebwohl, Adelaide Hebert, Andrew E. Pink, Yuling Shi, Megan Miller-Kassamali, Joseph Cafone, Jingzhi Jiang, Shu Li, Ya-Wen Yang, Lawrence F. Eichenfield
This document will be available on May 29 2026
One-year Efficacy and Safety Results From ICONIC-ADVANCE 1 and 2 in Adults With Moderate-to-Severe Plaque Psoriasis
Linda Stein Gold, April W. Armstrong, Jennifer Soung, Ronald B. Vender, Álvaro González Cantero, Matthias Hoffman, Ofelia Reyes-Servin, Bassey Effiom Edem, Kellen Cresswell, Ya-Wen Yang, Robert Bissonnette
This document will be available on May 29 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.